PSAP and colorectal carcinoma: Using quantitative label-free proteomics analysis, researchers have found that PSAP is more highly expressed in CRC subtypes linked to poorer prognosis, including consensus molecular subtype 4 (CMS4), Colorectal Cancer Intrinsic Subtype B (CRIS-B), and Stem-like subtype, compared with other subtypes.